Share

February 18, 2020; 94 (7) Views & Reviews

Seizure outcome of pediatric epilepsy surgery

Systematic review and meta-analyses

Elysa Widjaja, Puneet Jain, Lindsay Demoe, Astrid Guttmann, George Tomlinson, Beate Sander
First published January 29, 2020, DOI: https://doi.org/10.1212/WNL.0000000000008966
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
372

Share

Article Information

vol. 94 no. 7 311-321
DOI: 
https://doi.org/10.1212/WNL.0000000000008966
PubMed: 
31996452
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 2, 2019
  • Accepted in final form December 10, 2019
  • First Published January 29, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Elysa Widjaja, MD, MPH,
    2. Puneet Jain, MD,
    3. Lindsay Demoe, BA,
    4. Astrid Guttmann, MD,
    5. George Tomlinson, PhD and
    6. Beate Sander, PhD
  1. Elysa Widjaja, MD, MPH,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (i) American Journal of Neuroradiology, editorial board member, 2013-present (ii) Epilepsy and Behavior, editorial board member, 2017- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (i) Canadian Institute of Health Research, 133708, PI, 2014-2019 (ii) Ontario Brain Institute, PI, 2018-2023

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (i) Pediatric Epilepsy Research Foundation, PI, 2019-2021

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Puneet Jain, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Lindsay Demoe, BA,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Astrid Guttmann, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 2018 - 2022 Nominated-PI Optimizing Canada's Healthcare for REfugees (OCHRE). Canadian Institutes of Health Research: Project Scheme Grant. (Glazier R, Rayner J, Co- PIs) $585,224 CAD 2018 - 2020 Co-PI Building Partnerships with Southern Ontario First Nations around Indigenous Neonatal Abstinence Syndrome. ChildBright SPOR Network Grant. (Walker J, Co-PI) $319,233 CAD ($211,176 CAD from CIHR) 2012 - 2017 PI Evidence-Informed Health Services Delivery for Canadian Children and Youth. Canadian Institutes of Health Research Applied Chair in Reproductive, Child and Youth Health Services and Policy Research Award. $425,000 CAD – Operating funding

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. George Tomlinson, PhD and
    6. Scientific Advisory Boards:

    1. (1) Non-profit entity: Vanderbilt University Medical Centre, for position on DSMB of SPRINT clinical trial of hydroxyurea for prevention of recurrent stroke in children with sickle cell disease. (2) Non-profit entity: member of Ontario Cancer Research Ethics Board

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Non-profit entity, American Society of Hematology, compensation for travel and time spent as faculty at Clinical Research Training Institute, 20189 and 2019

    Editorial Boards:

    1. Canadian Medical Association Journal, biostatistical consultant, 2019

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Non-profit entity: St Michael's Hospital, Toronto, for consultation on analysis of clinical trial (2) Non-profit entity: CAMH, Toronto, for consultation on analysis of clinical trial

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. My role: co-investigator unles otherwise detailed Title: Clinical and Genetic Risk Factors for Atypical Femur Fractures Agency: CIHR, Project grant Years: 2018-2021 PI: Cheung, Angela M; Ito, Shinya Co-I: Bleakney, Robert R; Carleton, Bruce C; Rottapel, Robert K; Strug, Lisa J; Tomlinson, George A Title: Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy- induced Vomiting in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant Years: 2018-2022 PI: Dupuis, L. L co-I: Dvorak, Christopher C; Schechter-Finkelstein, Tal T; Spettigue, Wendy J; Sung, Lillian; Tomlinson, George A Title: Personalizing the Prevention of Osteoporotic Fracture Agency: CIHR Years: 2018-2019 PI: Cheung, Angela M; Tomlinson, George A Title: Metformin in Women with Type 2 Diabetes in Pregnancy (MiTy) Trial: A randomized controlled trial Agency: CIHR Years 2018-2020 PI: Feig, Denice S Co-I: Armson, Brian A; Asztalos, Elizabeth V; Barrett, Jon; Fantus, Ivan G; Lipscombe, Lorraine; Murphy, Kellie E; Ohlsson, Arne; Ryan, Edmond A; Simmons, David; Tomlinson, George A; Zinman, Bernard Title: Sleep and Pain in Childhood Arthritis: A crossover randomized control trial comparing adequate and restricted sleep duration, and its impact on pain in adolescents with arthritis Agency: CIHR Years: 2018-2020 PI: Feldman, Brian M Co-I: Beebe, Dean; Dover, Saunya; Narang, Indra; Stephens, Samantha; Stinson, Jennifer N; Tomlinson, George A; Weiss, Shelly K Title: A pragmatic registry-based randomized trial of drug tapering in rheumatoid arthritis Agency: CIHR Years: 2018-2021 PI: Hazlewood, Glen S; Bykerk, Vivian P Co-I: Bansback, Nicholas; Barber, Claire E; Bartlett, Susan J; Boire, Gilles; Deardon, Rob; Keystone, Edward C; Marshall, Deborah A; Pope, Janet E; Proulx, Laurie; Richards, Dawn; Schieir, Orit; Thorne, Carter J; Tomlinson, George A; Tugwell, Peter S Title: CAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease Agency: CIHR Years: 2017-2022 PI: Benseler, Susanna ; Swart, Joost ; Wulffraat, Nico Martinus ; Yeung, Rae Suk-Man Co-I: Bombardier, Claire ; Cafazzo, Joseph Anthony ; Eijkelkamp, Niels ; Goldenberg, Anna ; Guzman, Jaime ; IJzerman, Maarten ; Marshall, Deborah Anne ; Morris, Quaid Donald ; Prakken, Berent Jan ; Rosenblum, Norman David ; Scherer, Stephen Wayne ; Stinson, Jennifer Nan ; Twilt, Marinka ; Vastert, Sebastiaan ; ten cate, Rebecca My role: Co-investigator. Helped design parts of the protocol; will carry out some parts of and supervise other parts of the data analysis coming from the many projects the network will fund. Title: Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia Agency: NIH: NHLBI Years: 2017-2022 PI: Ware, Russell Co-I: McGann, Patrick; Tshilolo,Leon; Santos, Brigida; Tomlinson, George; Aygun, Banu; Obaro, Stephen; Olupot-Olupot, Peter, Williams, Tom; Odame, Isaac. My role: Co-investigator. Helped design the study and analytic plan; will carry out some parts of and supervise other parts of the data analysis. Title: Telephone-Based Cognitive Behavioural Therapy for Post- Operative Bariatric Surgery Patients: A Randomized Controlled Trial Agency: CIHR Years: 2017-2022 PI: Cassin, Stephanie E ; Sockalingam, Sanjeev Co-I: Du, Chau Thuy ; Hawa, Raed ; Lipscombe, Lorraine ; Okrainec, Allan ; Urbach, David Robert ; Wnuk, Susan Margaret My role: Co-investigator. Helped design the study and analytic plan; will carry out some parts of and supervise other parts of the data analysis. Title: Nicotinamide chemoprevention for keratinocyte carcinoma in solid organ transplant recipients: A randomized, placebo-controlled, internal pilot trial Agency: CIHR Years: 2017-2019 PI: Chan, An-Wen ; Kim, Sang Joseph Co-I: Herrmann, Nathan ; Knoll, Gregory ; Shear, Neil Hartley ; Singer, Lianne Gail ; Zaltzman, Jeffrey My role: Co-investigator. Helped design the study and analytic plan; will carry out some parts of and supervise other parts of the data analysis. Title: The MiTy Trial (Metformin in Women with Type 2 Diabetes in Pregnancy) Agency: CIHR Years: 2017-2018 PI: Denice Feig Co-I: Armson, Brian Anthony ; Asztalos, Elizabeth Vagi ; Fantus, Ivan George ; Lee, Shoo K. ; Lipscombe, Lorraine ; Murphy, Kellie Estelle ; Ohlsson, Arne ; Ryan, Edmond A. ; Zinman, Bernard My role: Co-investigator. Helped design the study and analytic plan; will carry out some parts of and supervise other parts of the data analysis. Title: Leveraging Electronic Medical Records and Health Administrative Data to Evaluate Patient Care and Outcomes in Osteoarthritis Agency: CIHR Years: 2017-2018 PI: Hawker, Gillian Alexandra ; Tu, Karen ; Widdifield, Jessica Co-I: Bernatsky, Sasha R ; Bombardier, Claire ; Butt, Debra Ann ; Ivers, Noah Michael Jaakkimainen, R. Liisa ; Jenkinson, Richard John ; Kuriya, Bindee ; Meaney, Christopher Andrew ; Morris, Quaid Donald ; Paterson, Michael ; Pope, Janet Elizabeth ; Ravi, Bheeshma ; Thorne, Carter J. ; Wasserstein, David ; Yann, Margot Lisa-Jing My role: Co-investigator. Helped design the study and analytic plan. Title: InCURS: Intensive Care Unit Residents Scheduling Study Agency: CIHR Years: 2017-2017 PI: Parshuram, Christopher S. ; Piquette, Dominique Co-I: Amaral, Andre Carlos Kajdacsy ; Ayas, Najib ; Bagshaw, Sean M ; Baker, G. Ross ; Brydges, Ryan ; Ferguson, Niall Douglas ; Frank, Jason ; Friedrich, Jan ; Imrie, Kevin R ; Karachi, Timothy ; Kirpalani, Haresh Murli ; Mema, Briseida ; Scales, Damon Cole ; Sen, Mithu ; Stelfox, Henry Thomas ; Andrew ; Walsh, Catharine Margaret ; Willan, Andrew Roger My role: Co-investigator. Helped design the study and analytic plan; will carry out some parts of and supervise other parts of the data analysis. Title: Pevention of postpartum hemorrhage: addressing critical knowledge gaps for the use of tranexamic acid. Agency: CIHR Years: 2017-2020 PI: Carvalho, Jose C.A. ; D'Souza, Rohan Dominic ; Krahn, Murray Dale ; Murphy, Kellie Estelle ; Sander, Beate Helga ; Shah, Prakeshkumar ; Shehata, Nadine ; Tomlinson, George Andrew ; Wasowicz, Marcin Co-I: Khanduja, Purva Kristina Title: Toward personalizing care for older men with mCRPC - understanding and predicting treatment toxicities (the TOPCOP study) Agency: Prostate Cancer Canada PI: Shabbir Alibhai Co-I: Berry, Scott ; Emmenegger, Urban ; Fleshner, Neil ; Hansen, Aaron ; Hotte, Sébastian ; Joshua, Anthony Years: 2015 –2018 My role: Co-investigator. Helped design the study and analytic plan; will carry out some parts of and oversee other parts of the data analysis. Title: Comparative Effectiveness of CARRA Treatment Strategies for Polyarticular Juvenile Idiopathic Arthritis Agency: Patient-Centered Outcome Research Institute (USA) PI: Yukiko Kimura Co-I: Sarah Ringold, Pamela Weiss, Marc Natter, Brian Feldman, Laura Schanberg Years: 2015 –2018 My role: Co-investigator. Helped design the study and analytic plan; will carry out some parts of and oversee other parts of the data analysis. Title: Protection against Incidences of Serious Cardiovascular Events Study with daily fish oil supplementation in dialysis patients(PISCES) Agency: Heart and Stroke Foundation PI: Charmaine Lok Co-I: Mike Farkouh, Louise Moist. Years: 2015 –2018 My role: Co-investigator. Helped design the study and analytic plan; will carry out or supervise the data analysis

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Beate Sander, PhD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Canadian Institutes for Health Research (CIHR): Apr 2019 – Mar 2024 Principal Investigator: Canada Research Chair in Economics of Infectious Diseases (Tier 2). Canadian Institutes of Health Research (CIHR), Canada Research Chairs. $600,000 CAD. Oct 2019 - Sep 2022 Co-Investigator: The Epidemiology and Economic Burden of Hepatitis C Viral infection in the First Nations Population in Ontario $650,250 CAD Operating Funding. Apr 2019 – Mar 2022: Principal Investigator: The Prevention of Group B Streptococcal (GBS) disease in infants. Canadian Institutes of Health Research (CIHR), Project Grant. Principal Investigators: Natasha Crowcroft (Nominated PI), Deshayne Fell, Beate Sander. Co-investigators: Jon Barrett, Shelly Bolotin, Kevin Brown, Nahuel Fittipaldi, Allison McGeer, Michelle Murti, Manish Sadarangani, Kevin Schwartz, Kumanan Wilson $409,276 CAD Operating Funding. Jun 2018 – May 2022 Principal Investigator: A National Research Network on Lyme Disease. Canadian Institutes of Health Research (CIHR), Team Grant. Principal Investigators: Kieran Moore (Nominated PI), Cécile Aenishaenslin, George Chaconas, Rylan Egan, Todd Hatchette, Manisha Kulkarni, Patrick Leighton, Tara Moriarty, Muhammad Morshed, Janet Parsons, Samir Patel, Deanna Bubola, Marg Cox, Lorette Anne Dennis, Donna Enright, Bruce Roxburgh, Beate Sander, Triant Steuart, Miriam Verheyden, Heather Wise. Co-Investigators: 78 Co-Investigators $4,000,000 CAD. Network Funding. Oct 2018–Sep 2021 Co-Investigator: Comprehensive Ontario Microbiology laBoratory Administrative daTa for AntiMicrobial Resistance (COMBAT-AMR) Canadian Institutes of Health Research (CIHR), Project Grant. Principal Investigators: Kevin Brown, Nick Daneman Co-Investigators: Vanessa Allen, Gary Garber, Jennie Johnstone, Bradley Langford, Derek MacFadden, Samir Patel, Frank Rudzicz, Beate Sander, Kevin Schwartz, Therese Stukel, Margot Yann $608,176 CAD. Operating funding. Mar 2018–Feb 2019 Co-Investigator: The cost-utility of active surveillance compared with initial treatment for low risk prostate cancer in the “real world”: A population-based study from the Canadian healthcare payer perspective University of Toronto, Astellas Grant, 2018 Principal Applicant: Shabbir Alibhai Co-Applicants: Antonio Finelli, Beate Sander, George Tomlinson, Narhari Timilshina $50,000 CAD. Operating funding. Apr 2018–Mar 2021 Principal Investigator: Achieving hepatitis C elimination in Canada; addressing the needs of the diverse groups at risk Canadian Institutes of Health Research (CIHR), Project Grant. Principal Investigators: Christina Greenaway (Nominated PI), Naveed Janjua, Jeff Kwong, Beate Sander Co-Investigators: Laurent Azoulay, Karine Blouin, Julie Bruneau, Melisa Dickie, Jordan Feld, Murray Krahn, Mel Krajden, Lauren Lapointe-Shaw, Donald Murphy, Michael Otterstatter, Robert Platt, Eleanor Pullenayegum, Hasina Samji, Mark Tyndall, Bryna Warshawsky, William Wong $1,197,225 CAD. Operating funding. Oct 2017–Sep 2020 Principal Investigator: Prevention of postpartum haemorrhage: addressing knowledge gaps for the use of tranexamic acid. Canadian Institutes of Health Research (CIHR), Operating Grant. Principal Investigators: Rohan D’Souza (Nominated PI), Jose Carvalho, Murray Krahn, Kellie Murphy, Beate Sander, Prakesh Shah, Nadine Shehata, George Tomlinson, Marcin Wasowicz Co-Investigators: Kristina Khanduja $225,000 CAD. Operating funding. Oct 2017–Sep 2019 Co-Investigator: Global Fibrosis Network. Connaught Fund. Connaught Global Challenge Award. Principal Investigator: Craig Simmons Co-Investigators: Richard Gilbert, Christopher McCulloch, Beate Sander $250,000 CAD. Network funding. Apr 2017–Mar 2020 Co-Investigator: From Patient to Policy: Using data to drive TB elimination in Canada's foreign born population. Canadian Institutes of Health Research (CIHR), Project Scheme Grant. Principal Investigators: James Johnston, Sarah Brode, Christina Greenaway, Naveed Janjua, Kevin Schwartzman Co-Investigators: Faiz Ahmad Khan, Robert Balshaw, Michael Campitelli, Victoria Cook, Frances Jamieson, Jeffrey Kwong,Liane Macdonald, Fawziah Marra, Theodore Marras, Maureen Mayhew, Richard Menzies, Kevin Pottie, Elizabeth Rea, Beate Sander $1,208,699 CAD. Operating funding. OTHER: Jul 2019 - Nov 2019; Principal Investigator: Economic Evaluation of Palivizumab Vaccination. Public Health Agency of Canada. $24,750. Operating funding. Aug 2018 - Aug 2019; Principal Investigator: Evidence to Decision Framework: Influenza Diagnostics. World Health Organization. $18,647. Operating funding.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Institute of Health Policy, Management and Evaluation (E.W., A.G., G.T., B.S.), University of Toronto, ON, Canada; Diagnostic Imaging (E.W.); Division of Neurology (E.W., P.J.); Neuroscience and Mental Health (L.D.), Hospital for Sick Children, Toronto; ICES (A.G., B.S.), Toronto, ON, Canada; Department of Pediatrics (A.G.), Hospital for Sick Children, Toronto, ON, Canada; Toronto Health Economics and Technology Assessment (THETA) Collaborative (G.T., B.S.), University Health Network, Toronto, ON, Canada; and Public Health Ontario (B.S.), Toronto, ON, Canada.
  1. Correspondence
    Dr. Widjaja Elysa.Widjaja{at}sickkids.ca
View Full Text

Article usage

Article usage: January 2020 to March 2023

AbstractFullPdfSource
Jan 2020129010Highwire
Feb 20208343949Highwire
Mar 20202082824Highwire
Apr 20201681922Highwire
May 2020276912Highwire
Jun 20201841212Highwire
Jul 202012556Highwire
Aug 2020119613Highwire
Sep 2020132615Highwire
Oct 20209465Highwire
Nov 20209068Highwire
Dec 202096511Highwire
Jan 20211941314Highwire
Feb 202112866Highwire
Mar 202112065Highwire
Apr 202115833Highwire
May 20211371115Highwire
Jun 20219069Highwire
Jul 20219654Highwire
Aug 202112067Highwire
Sep 20218945Highwire
Oct 202114784Highwire
Nov 2021120124Highwire
Dec 202113663Highwire
Jan 20227766Highwire
Feb 202282107Highwire
Mar 20221011110Highwire
Apr 20221162110Highwire
May 2022114139Highwire
Jun 20228667Highwire
Jul 202285128Highwire
Aug 202215665Highwire
Sep 2022111125Highwire
Oct 20222141618Highwire
Nov 2022135177Highwire
Dec 2022120136Highwire
Jan 202312574Highwire
Feb 202313384Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles